Adrienne L. Graves, Ph.D.
Board Member
Ocular Therapeutix, Inc (OCUL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Adrienne L. Graves, Ph.D.
Adrienne L. Graves, Ph.D. is recorded as Board Member at Ocular Therapeutix, Inc (OCUL). Ocular Therapeutix, Inc reported in an 8-K filed June 14, 2024 that Adrienne L. Graves, Ph.D. was appointed Class I director, effective June 12, 2024. Ocular Therapeutix, Inc reported in an 8-K filed July 12, 2023 that Adrienne L. Graves, Ph.D. was appointed member of the Board, effective July 10, 2023.
“The Company's stockholders elected Adrienne L. Graves, Ph.D. and Charles Warden as Class I directors to serve until the 2027 Annual Meeting of Stockholders, each such director to hold office until her or his successor has been duly elected and qualified.”
“On July 10, 2023 (the “Effective Date”), the board of directors (the “Board”) of Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), following the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Adrienne L. Graves, Ph.D., to serve as a member of the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-14–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ocular Therapeutix, Inc
Other people whose current roles at this company are on record from its filings.
- Pravin Dugel CEO
- Pravin U. Dugel CEO, Chairman, Board Member
- Pravin U. Dugel, M.D. CEO, Chairman
- Charles Warden Chairman, Board Member
- Jason Robins CFO
- Donald Notman COO
- Philip C. Strassburger General Counsel
- Adrienne L. Graves Board Member
- Jeffrey Heier Board Member
- Jeffrey S. Heier, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.